Birdwatch Note Rating
2024-08-14 07:01:14 UTC - NOT_HELPFUL
Rated by Participant: D8642179B82826B193E92B1B1C59AB7E06F39463C4AD55F752528D66FB20FEFD
Participant Details
Original Note:
The scholarly articles have report "...These results suggest that a third dose of BNT162b2 is safe, improves humoral immunity against SARS-CoV-2, and could be immunologically beneficial for cancer patients on active chemotherapy." : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004706/ A scientific study is needed NOT speculation
All Note Details